Promising early results from a clinical trial at the Mayo Clinic out this week suggest that a modified version of the measles virus can be used to target cancer cells and put the condition into remission.
fastcoexist.com - About the author Ben Schiller is a New York staff writer for Fast Company. Previously, he edited a European management magazine and was a reporter in San Francisco, Prague, and Brussels. More
Resistance to antibiotics poses a "major global threat" to public health, says a new report by the World Health Organization (WHO). It analysed data from 114 countries and said resistance was happening